Come up with a name for your new list and we'll add to it:
Sequenta raised a round of funding on July 15, 2009. Investors include
Mohr Davidow Ventures.
Sequenta, formerly MLC Dx, is a biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. Sequ…